The well-marked improvements in hepatic steatosis, coupled with the decreased adiposity observed in the ALL group, was related with the decreases in the plasma glucose and insulin levels, which was a reflection of ameliorated hepatic insulin sensitivity [35], as evidenced by a reduced area under the curve for the IPGTT. The gene discussed is INS; the disease is fatty liver disease.